Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway

Institutions

Publication Details

Journal
Frontiers in Pediatrics
Published
2025-06-16
DOI
https://doi.org/10.3389/fped.2025.1640136
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway

Frontiers in Pediatrics
Galectins and Cancer Biology
article

Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway

article en

Abstract

No abstract available for this paper.
Frontiers in PediatricsVol. 13
National Research Council (LK)
Zero hunger
Openalex Percentile: Top 85%
Galectins and Cancer Biology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway · Frontiers in Pediatrics (2025) | TGRS Research Map | TGRS